← Back
Data updated: Mar 10, 2026
BLUEPRINT MEDICINES
OncologyGastroenterology
BLUEPRINT MEDICINES is a pharmaceutical company focused on Oncology, Gastroenterology. Key products include AYVAKIT.
2020
Since
2
Drugs
-
Trials
3
Approved (2yr)
Key Drugs
Recent Activity
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Oncology 64%
1 drugs Phase 2: 1 Phase 1: 10
Gastroenterology 36%
1 drugs Phase 1: 4
Pipeline Strength Pro
Loading...